Current Consultations

Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.

The following lists both consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia updates this regularly but we may not participate in every one listed.

If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia via email greg.mullins@researchaustralia.org or phone (03) 9662 9420.

Please click the heading in the left hand column to access consultation information from the relevant website.

Consultation

Details

Self-testing in vitro diagnostic medical devices (IVDs) in Australia

 

Due 22 November

The TGA is seeking comments from interested parties as to whether the Therapeutic Goods (Excluded Purposes) Specification 2010 continues to serve a useful and necessary purpose in prohibiting supply of direct to consumer:

(a) Tests for the presence of, or exposure to, pathogenic organisms or transmissible agents (other than the Human Immunodeficiency Virus), including agents that cause notifiable infectious diseases;

(b) Genetic tests to determine the presence of, or susceptibility to, diseases in humans;

(c) Tests to diagnose, aid in diagnosis or indicate the presence of a serious disease or condition, such as cancer or myocardial infarction;

(d) Tests for the presence of markers that are precursors to a serious disease or condition, such as Pap smear tests (marker for cervical cancer) or prostate specific antigen tests (marker for prostate cancer).

The feedback received in response to the consultation will inform a recommendation to the Minister on whether to remake the Excluded Purposes Specification after it automatically expires (sunsets) in October 2020.

Fetal Alcohol Syndrome Disorder Senate Inquiry

 

 

Due 29 November

The Senate Community Affairs References Committee is undertaking an Inquiry into Fetal Alcohol Spectrum Disorder (FASD).

The terms of reference include effective approaches to prevention and diagnosis of Fetal Alcohol Spectrum Disorder (FASD), strategies for optimising life outcomes for people with FASD and supporting carers, and the prevalence and management of FASD, including in vulnerable populations, in the education system, and in the criminal justice system.  Submissions can be made now.

Implementing the Third Review of the Gene Technology Scheme: Phase 1

 

Due 29 November

An Issues Paper to inform three key priority areas arising from the Third Review of the National Gene Technology Scheme (the Review), has been developed.

Of particular interest is the Review’s recommendation six, that:

a) the definition of a genetically modified organism under the Gene Technology Act 2000 (Cth) be amended to clarify that humans are not considered to be GMOs; and that

b) subject to consideration, the COAG (Council of Australian Governments) Health Council might also consider whether additional regulatory oversight is needed for humans who may receive or inherit germline therapies (or other somatic therapies not within the remit of the Scheme). The COAG Health Council should also consider which regulatory (or other) body would be most appropriate to undertake such oversight.

The issues paper is available from the website (a link is embedded in the heading on the left).

Accelerating R&D in NSW

 

Due 13 December

The NSW Government is seeking feedback from organisations and individuals engaged in research and development (R&D) in NSW.

The government is seeking to answer:

·       how do we get the most out of NSW Government’s R&D activity

·       how can the NSW Government support and improve the R&D and commercialisation ecosystem more generally?

Participation is through an online survey.

Obesity Strategy

 

Due 15 December

The Australian and state and territory governments through the COAG Health Council have agreed to develop a national obesity strategy to address this significant public health challenge.

A consultation paper is available to guide participation through the survey, public forums, community discussions and webinars.

Pre- Budget Submissions

 

Due 20 December

 

The Assistant Treasurer, the Hon. Michael Sukkar MP, is seeking submissions from individuals, businesses and community groups on their views for priorities for the 2020-21 Budget.

If you would like to contribute to Research Australia’s Pre-Budget submission, please contact Greg Mullins, Head of Policy. greg.mullins@researchaustralia.org

Productivity Commission- Mental Health

 

Due 23 January 2020

The Productivity Commission released its Draft Report on Mental Health on 31 October, and is now seeking comments.

‘The cost to the Australian economy of mental ill-health and suicide is, conservatively, in the order of $43 to $51 billion per year. Additional to this is an approximately $130 billion cost associated with diminished health and reduced life expectancy for those living with mental ill-health.’

The Draft report has identified five key reform areas, including to research into mental health and the mental health system.

If you are interested in contributing to Research Australia’s submission please contact Greg Mullins, Head of Policy at greg.mullins@researchaustralia.org or on 03 9662 9420.